Theriva Biologics, Inc.

Theriva Biologics, Inc. - PE Ratioverified

TOVX

Price:

$0.2511

Market Cap:

$8.96M

Theriva Biologics Inc. is a clinical-stage biotechnology firm dedicated to developing novel treatments for conditions with significant unmet medical needs. The company's pipeline features several promising candidates, including SYN-004, which is engineered to break down commonly used intravenous beta-lactam antibiotics in the gastrointestinal tract. This degradation aims to avert microbiome damage, Clostridioides difficile infection (CDI), the overgrowth of harmful organisms, the rise of antimicrobial resistance (AMR), and acute graft-versus-host disease (aGVHD) in patients undergoing allogeneic hematopoietic cell transplants. Another key investigational therapy is SYN-020, an orally adminis...[Read more]

Industry

Biotechnology

IPO Date

2006-12-18

Stock Exchange

AMEX

Ticker

TOVX

The PE Ratio as of June 2026 (TTM) for Theriva Biologics, Inc. (TOVX) is -0.43

According to Theriva Biologics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.43. This represents a change of -4.23% compared to the average of -0.45 of the last 4 quarters.

Theriva Biologics, Inc. (TOVX) Historical PE Ratio (quarterly & annually)

How has TOVX PE Ratio performed in the past?

The mean historical PE Ratio of Theriva Biologics, Inc. over the last ten years is -24.50. The current -0.43 PE Ratio has changed 75.53% with respect to the historical average. Over the past ten years (40 quarters), TOVX's PE Ratio was at its highest in in the December 2017 quarter at 148.97. The PE Ratio was at its lowest in in the December 2016 quarter at -208.31.

Quarterly (TTM)
Annual

Average

-24.50

Median

-10.20

Minimum

-107.45

Maximum

-0.09

Theriva Biologics, Inc. (TOVX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Theriva Biologics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 146.88%

Maximum Annual PE Ratio = -0.09

Minimum Annual Increase = -99.03%

Minimum Annual PE Ratio = -107.45

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.1010.00%
2024-0.09-75.63%
2023-0.388.39%
2022-0.35-99.03%
2021-35.82146.88%
2020-14.514.63%
2019-13.87112.44%
2018-6.53-93.93%
2017-107.4563.08%
2016-65.89-37.56%

Theriva Biologics, Inc. (TOVX) Average PE Ratio

How has TOVX PE Ratio performed in the past?

The current PE Ratio of Theriva Biologics, Inc. (TOVX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.19

5-year avg

-7.35

10-year avg

-24.50

Theriva Biologics, Inc. (TOVX) PE Ratio vs. Peers

How is TOVX’s PE Ratio compared to its peers?

Theriva Biologics, Inc.’s PE Ratio is less than Galmed Pharmaceuticals Ltd. (-0.25), greater than BioVie Inc. (-1.20), less than NKGen Biotech, Inc. Common Stock (-0.12), less than PMGC Holdings Inc. (-0.01), less than Moolec Science S.A. (-0.03), less than iSpecimen Inc. (-0.01), less than Windtree Therapeutics, Inc. (-0.00), less than BriaCell Therapeutics Corp. Warrant (-0.24), greater than Chemomab Therapeutics Ltd. (-1.38), less than Carisma Therapeutics, Inc. (0.10),

Build a custom stock screener for Theriva Biologics, Inc. (TOVX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theriva Biologics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theriva Biologics, Inc. (TOVX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theriva Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Theriva Biologics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Theriva Biologics, Inc. (TOVX)?

What is the highest PE Ratio for Theriva Biologics, Inc. (TOVX)?

What is the 3-year average PE Ratio for Theriva Biologics, Inc. (TOVX)?

What is the 5-year average PE Ratio for Theriva Biologics, Inc. (TOVX)?

How does the current PE Ratio for Theriva Biologics, Inc. (TOVX) compare to its historical average?